Pathways related to immunity and inflammation were also enriched, including “C-type lectin receptor,” “TNF,” and “PI3K-Akt” signaling pathways, suggesting that both innate and adaptive immune responses are still active in SSc-PF even in late stage disease (Supplementary Figure 6). This evidence concerns the gene AKT1 and systemic sclerosis.